Skip to main content
Erschienen in: Reactions Weekly 1/2017

01.03.2017 | Case report

Methotrexate

Laryngotracheal mucormycosis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Mattioni J, et al. Laryngotracheal mucormycosis: Report of a case. Ear, Nose, and Throat Journal 95: 29-39, No. 1, Jan 2016 - USA Mattioni J, et al. Laryngotracheal mucormycosis: Report of a case. Ear, Nose, and Throat Journal 95: 29-39, No. 1, Jan 2016 - USA
Metadaten
Titel
Methotrexate
Laryngotracheal mucormycosis: case report
Publikationsdatum
01.03.2017
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2017
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-017-27972-9

Weitere Artikel der Ausgabe 1/2017

Reactions Weekly 1/2017 Zur Ausgabe

Case report

Cefepime

Case report

Glycopyrrolate

Case report

Multiple drugs

Case report

Clopidogrel

Case report

Tacrolimus

Case report

Gliclazide